ERS International Congress, Milan 2017

---

What is new in COPD diagnosis and classification?

Thematic Poster
Chairs: T. Lapperre (København NV, Denmark), R. Jordan (Birmingham, United Kingdom), K. Chapman (Toronto, ON, Canada), E. Mekov (Sofia, Bulgaria)

Validation of the GOLD 2017 classification in a Chinese COPD cohort J. Fu (Chengdu, Sichuan, China)
Stability of the exacerbation pattern defined by GOLD 2017 in a real-world COPD population J. Fu (Chengdu, Sichuan, China)
Determinants of re-hospitalizations due to acute exacerbation of COPD M. Erro (Madrid, Spain)
Evaluation of respiratory symptoms in COPD patients from seven Latin America countries: The LASSYC Study M. Miravitlles (Barcelona, Spain)
The prevalence of the chronic obstructive pulmonary disease in the city of Telavi, Georgia: a cross-sectional study. I. Chkhaidze (Tbilisi, Georgia)
BODE INDEX IN DIFFERENT PHENOTYPES OF COPD A. Corlateanu (Chisihau, Republic of Moldova)
Predictors of multiple admissions of COPD patients: about 1167 cases A. Ben Saad (Monastir, Tunisia)
Influence of previous admissions on audit outcomes in patients admitted with acute exacerbation of COPD (AECOPD) J. Holzhauer-Barrie (London, United Kingdom)
Classifying patients as GOLD A–D using the 2017 strategy criteria: impact on efficacy by GOLD stage in the OTEMTO tiotropium+olodaterol clinical trials D. Singh (Manchester, United Kingdom)
Is diaphragmatic thickness fraction valuable in identifying high-risk chronic obstructive pulmonary disease patients? E. Eryüksel (Istanbul, Turkey)
Discordance between a patient completed COPD Assessment test (CAT) and a CAT completed by patient with physician assistance V. Koblizek (Hradec Králové, Czech Republic)
Association between third-space fluid and FEV1 in COPD patients A. Jimenez Cepeda (saltillo, Mexico)
The  Validity of Indonesian Society of Respirology (ISR) Version of COPD Screening Questionnaire Y. Sutanto (surakarta, Indonesia)
Factors acting on the duration of hospitalization in COPD H. Rouis (Tunis, Tunisia)
Comparison between electronic and paper versions of the Evaluating Respiratory Symptoms in COPD (E-RS) and the COPD Assessment Test (CAT). K. Nishimura (Kyoto, Japan)
The prognostic role of the bronchiectasis in patients with COPD E. Kim (Seongnam-si, Republic of Korea)
Differences between GOLD Group C and D: More than mMRC or CAT A. Ben Saad (Monastir, Tunisia)
Level of control of Chronic Obstructive Pulmonary Disease according to clinical phenotypes. Study SINCON A. Baloira (Pontevedra, Spain)
The impact of grouping patients by the 2017 GOLD COPD strategy on response to therapy: post hoc results from the TONADO tiotropium+olodaterol trials G. Ferguson (Farmington Hills, United States of America)